The group of Xin XIE at Shanghai Institute of Materia Medica has found that bromodeoxyuridine can replace Oct4 in mouse embryonic fibroblasts, the most critical factor in the „Yamanaka factors“ used for cell reprogramming.
CAS news release, August 19, 2015